Oriomics' Liver Cancer Screening Reagent Earns FDA Breakthrough Device Designation
CompanyMedical Device

Oriomics’ Liver Cancer Screening Reagent Earns FDA Breakthrough Device Designation

Kexing Biopharm Partners with BioMap on AI-Driven Macromolecular Drug Development
CompanyDeals

Kexing Biopharm Partners with BioMap on AI-Driven Macromolecular Drug Development

CStone Pharmaceuticals Files for EMA Approval of Sugemalimab for Unresectable Stage III NSCLC
CompanyDrug

CStone Pharmaceuticals Files for EMA Approval of Sugemalimab for Unresectable Stage III NSCLC

Abbisko Therapeutics and Allist Pharmaceuticals Partner on KRAS-G12C NSCLC Combination Therapy
CompanyDeals

Abbisko Therapeutics and Allist Pharmaceuticals Partner on KRAS-G12C NSCLC Combination Therapy

Eli Lilly Launches Lilly Gateway Laboratory in China to Boost Biotech Innovation
Company

Eli Lilly Launches Lilly Gateway Laboratory in China to Boost Biotech Innovation

Clover Biopharmaceuticals Receives FDA Approval for SCB-1019 RSV Vaccine Trial
CompanyDrug

Clover Biopharmaceuticals Receives FDA Approval for SCB-1019 RSV Vaccine Trial

AIM Vaccine's mRNA-based Shingles Vaccine Receives FDA Approval for Clinical Study
CompanyDrug

AIM Vaccine’s mRNA-based Shingles Vaccine Receives FDA Approval for Clinical Study

NMPA Updates Rules on Domestic Production of Imported Medical Devices
Medical DevicePolicy / Regulatory

NMPA Updates Rules on Domestic Production of Imported Medical Devices

Broncus Medical's BroncQCT Approved by Zhejiang Administration for China Market Entry
CompanyMedical Device

Broncus Medical’s BroncQCT Approved by Zhejiang Administration for China Market Entry

Lifetech Scientific's LAmbre Plus LAA Closure System Gains US Medical Insurance Coverage
CompanyMedical Device

Lifetech Scientific’s LAmbre Plus LAA Closure System Gains US Medical Insurance Coverage

Hansoh Pharmaceutical Reports 21% Revenue Growth, Boosted by Innovative Drugs
Company

Hansoh Pharmaceutical Reports 21% Revenue Growth, Boosted by Innovative Drugs

Johnson & Johnson Pledges USD55 Billion for US Expansion, Focusing on Manufacturing and R&D
Company

Johnson & Johnson Pledges USD55 Billion for US Expansion, Focusing on Manufacturing and R&D